Previous Close | 126.98 |
Open | 127.25 |
Bid | 124.99 x 800 |
Ask | 129.27 x 800 |
Day's Range | 125.42 - 127.33 |
52 Week Range | 119.59 - 148.62 |
Volume | |
Avg. Volume | 1,034,317 |
Market Cap | 13.983B |
Beta (5Y Monthly) | 0.89 |
PE Ratio (TTM) | 16.81 |
EPS (TTM) | 7.49 |
Earnings Date | Apr 23, 2024 |
Forward Dividend & Yield | 3.00 (2.36%) |
Ex-Dividend Date | Apr 05, 2024 |
1y Target Est | 142.29 |
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics' (DGX) base business performance in the first quarter of 2024.
NORTHAMPTON, MA / ACCESSWIRE / April 15, 2024 / Quest for Health Equity (Q4HE) was recently honored by the Y in Central Maryland for its grant funding of health equity coalition efforts at the Y in Druid Hill. Bob Kocher, Laboratory Manager at Quest's ...